13D/13G Filings - GKCC LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-09-27
9:36 pm
Purchase
2024-06-07 13G Xilio Therapeutics, Inc.
XLO
GKCC LLC 7,000,000
15.900%
7,000,000increase
(New Position)
Filing
History
2024-08-14
5:01 pm
Purchase
2024-08-12 13D Elicio Therapeutics, Inc.
ELTX
GKCC LLC 5,595,108
38.700%
3,442,341increase
(+159.90%)
Filing
History
2024-07-02
4:39 pm
Purchase
2024-06-28 13D Elicio Therapeutics, Inc.
ELTX
GKCC LLC 2,152,767
19.990%
109,587increase
(+5.36%)
Filing
History
2024-05-22
4:33 pm
Purchase
2024-05-14 13G MiNK Therapeutics, Inc.
INKT
GKCC LLC 464,000
11.790%
464,000increase
(New Position)
Filing
History
2024-03-20
4:37 pm
Purchase
2024-03-19 13D Elicio Therapeutics, Inc.
ELTX
GKCC LLC 2,043,180
19.990%
123,016increase
(+6.41%)
Filing
History
2023-12-26
4:25 pm
Purchase
2023-12-22 13D Elicio Therapeutics, Inc.
ELTX
GKCC LLC 1,920,164
19.990%
1,213,000increase
(+171.53%)
Filing
History
2023-09-22
4:17 pm
Purchase
2023-09-22 13G Nascent Biotech, Inc.
NBIO
GKCC LLC 10,000,000
6.300%
10,000,000increase
(New Position)
Filing
History
2023-08-30
4:15 pm
Purchase
2023-08-21 13D Immix Biopharma, Inc.
IMMX
GKCC LLC 3,255,734
19.990%
3,255,734increase
(New Position)
Filing
History
2023-06-14
2:42 pm
Purchase
2023-06-01 13D Elicio Therapeutics, Inc.
ELTX
GKCC LLC 707,164
8.400%
707,164increase
(New Position)
Filing
History